Melatonin Side Effects Long-Term: What the Research Shows

Dr. Sarah Mitchell, PhD (Stanford Sleep Research Center) reviews the current evidence on melatonin side effects and long-term safety — a topic of increasing urgency as melatonin has become one of the most widely used supplements in the world while remaining one of the least rigorously studied. In the United States alone, melatonin sales exceeded $900 million in 2024, with most users taking doses far above what the research supports. This article synthesizes findings from peer-reviewed studies, the circadian biology work of Russell Foster at Oxford, and cautionary perspectives from Matthew Walker at UC Berkeley to give you the clearest evidence-based picture of what melatonin can and cannot safely do.

What Melatonin Actually Is (and Is Not)

Melatonin is often called a "sleep hormone," but this label fundamentally mischaracterizes its biological role. Melatonin is a circadian timing signal — a chemical messenger synthesized by the pineal gland in response to darkness and suppressed by light exposure, particularly blue-spectrum light. Its primary biological function is to signal to the body's tissues and organs that nighttime has arrived, enabling the coordinated physiological preparation for sleep.

Russell Foster, Professor of Circadian Neuroscience at Oxford and one of the world's leading authorities on the biology of sleep timing, emphasizes that melatonin does not generate sleep — it prepares the body to transition into sleep at the appropriate circadian time. This distinction matters enormously for understanding what melatonin supplementation can realistically do and what its risks are when misapplied.

Melatonin's role as a circadian phase-shifting agent is supported by robust evidence. Its role as a simple sleep-onset medication — which is how most people use it — is supported by much weaker evidence at the doses commonly sold commercially.

The Dose Problem: Why Most People Take Too Much

The single most important and least-known fact about melatonin supplementation is the extreme mismatch between commercially available doses and what the research supports. The human body produces melatonin in quantities that produce blood concentrations of roughly 100–150 picograms per milliliter at peak — typically around 2–3 AM in a normal sleeper. Studies by Josephine Arendt at the University of Surrey, one of the pioneering researchers in melatonin chronobiology, showed that 0.3–0.5 mg of supplemental melatonin produces blood levels closely matching this natural peak.

Yet the most commonly sold supplement doses in the United States are 5 mg and 10 mg. A 5 mg dose produces blood melatonin concentrations approximately 10 to 20 times higher than physiological levels. A 10 mg dose may produce levels 30 to 50 times above normal. These supraphysiological levels do not proportionally improve sleep outcomes — they create a prolonged hormonal environment that can cause morning grogginess, dysregulate the normal melatonin signaling cycle, and may have downstream hormonal effects that are not yet fully characterized.

A 2023 study in the Journal of Clinical Sleep Medicineanalyzed melatonin supplement labeling accuracy and found that many products contained significantly more melatonin than stated on the label — in some cases over 400% more. This regulatory gap is unique to the supplement market and means that even a user intentionally selecting a "1 mg" product may be consuming considerably more.

Validated Uses: Where Melatonin Actually Works

Jet Lag

The most robustly supported use of melatonin is for jet lag — the temporary circadian misalignment that follows rapid transmeridian travel. A Cochrane review of 10 randomized controlled trials (Herxheimer & Petrie) concluded that melatonin is remarkably effective for preventing or reducing jet lag when used correctly. The key words are "used correctly": melatonin must be taken at the destination bedtime (not at home bedtime) and at physiologically appropriate doses (0.5–3 mg). Higher doses do not improve the circadian phase-shifting effect.

Delayed Sleep Phase Disorder

People with Delayed Sleep Phase Disorder (DSPD) — a circadian rhythm disorder in which the natural sleep window is shifted several hours later than socially desirable — show genuine benefit from low-dose melatonin taken in the early evening (5–7 hours before the desired sleep time). This application uses melatonin precisely as its biology intends: as a phase-shifting signal, taken at a time that advances the circadian clock. Adolescents and young adults, who disproportionately experience DSPD, represent an important clinical population where careful melatonin use is justified.

Shift Work

Shift workers — who must sleep at circadian times misaligned with light-dark cycles — can use melatonin to facilitate daytime sleep after night shifts. Evidence supports modest improvements in daytime sleep duration and quality in this population, though the gains are generally modest compared to the profound circadian disruption that shift work creates.

Long-Term Side Effects: What the Research Shows

Endogenous Production Suppression

The most theoretically plausible long-term risk of nightly melatonin supplementation is suppression of the pineal gland's own melatonin production through negative feedback mechanisms. When an external signal consistently substitutes for an endogenous one, the body may down-regulate its own production. This is well-established for other hormones — the basis of the rebound cortisol suppression seen after chronic steroid use. Whether it applies to melatonin with the same magnitude is not definitively established, but it is a mechanistically plausible concern.

A 2017 meta-analysis published in PLOS ONE found that chronic melatonin supplementation produced measurable changes in the amplitude of the endogenous melatonin rhythm in some participants, though the evidence was not uniform across studies. The clinical significance of reduced rhythm amplitude — beyond the immediate supplementation period — remains an open question.

Reproductive and Hormonal Effects

Melatonin receptors (MT1 and MT2) are expressed throughout the reproductive system, including the hypothalamus, pituitary gland, gonads, and uterus. Melatonin plays a role in the seasonal regulation of reproduction in photoperiodic mammals, and its receptors in human reproductive tissue suggest biological relevance that is not yet fully understood. Studies in animal models have shown that supraphysiological melatonin supplementation can alter LH pulsatility and estrogen production. The human evidence is less clear, but several case reports associate high-dose melatonin use with menstrual irregularities, and a 2020 review in Reproductive Biology and Endocrinologycalled for prospective studies of melatonin's effects on fertility in women of reproductive age.

Matthew Walker, in Why We Sleep, explicitly cautions against melatonin as a casual nightly supplement, noting that its hormonal effects on the reproductive system are an underappreciated dimension of the long-term safety question.

Drug Interactions

Melatonin is metabolized primarily by the CYP1A2 enzyme in the liver, creating meaningful drug interaction potential:

Anticoagulants (warfarin): Melatonin may enhance the anticoagulant effect of warfarin, increasing bleeding risk. This interaction is clinically significant.
CNS depressants: Additive sedation with benzodiazepines, Z-drugs, and alcohol — increasing the risk of excessive sedation and psychomotor impairment.
Immunosuppressants: Melatonin has immunomodulatory effects and may interfere with cyclosporine and other immunosuppressant drugs.
Fluvoxamine (Luvox): This SSRI inhibits CYP1A2 and can increase melatonin blood levels dramatically — by up to 17-fold. The combination requires medical supervision.
Caffeine: Also metabolized by CYP1A2, caffeine can affect melatonin clearance rates.

Children and Adolescents: Special Concerns

Melatonin use in children has grown dramatically, driven by the rise in pediatric insomnia diagnoses and the perception that melatonin is a safe, natural alternative to pharmaceutical sleep aids. The concern is that children and adolescents are still developing hormonally, and the reproductive system effects of chronic supraphysiological melatonin exposure during puberty are not established in human studies. The American Academy of Sleep Medicine has called for caution and recommends that pediatric melatonin use be under physician guidance. For children with neurodevelopmental conditions (autism, ADHD) where melatonin use is better studied and often clinically appropriate, the benefit-risk calculation is different.

What Works Better Than High-Dose Melatonin

The most effective evidence-based intervention for chronic insomnia is not melatonin — it is Cognitive Behavioral Therapy for Insomnia (CBT-I), which produces superior long-term outcomes compared to any sleep medication, without side effects or dependency risk. See our guide on CBT-I for insomnia for a complete breakdown.

For people looking to support sleep naturally, magnesium glycinate has a more mechanistically coherent and clinically supported profile than high-dose melatonin for general sleep support. Our article on magnesium glycinate for sleep and anxiety reviews the evidence in detail.

Behavioral interventions — consistent sleep scheduling, strategic light management in the morning and evening, and the full evidence-based protocol covered in our sleep hygiene guide — address the circadian and homeostatic drivers of poor sleep more fundamentally than any supplement.

Recommended Reading: Why We Sleep — Matthew Walker — Covers the science of sleep architecture, the dangers of sleep deprivation, and a measured critique of common sleep supplements including melatonin. Required reading for anyone taking sleep health seriously. Available on Amazon.

Practical Recommendations

If you choose to use melatonin, the evidence supports the following approach:

Use the lowest effective dose: Start with 0.3–0.5 mg. Work up to 1 mg only if lower doses are insufficient. Avoid 5–10 mg doses for routine use.
Time it correctly: For sleep onset support, take 30–60 minutes before the desired sleep time. For jet lag, take at the destination bedtime. Timing matters more than dose.
Use it for the right purpose: Circadian phase adjustment (jet lag, shift work, DSPD) is where the evidence is strongest. Chronic nightly use for general insomnia is where the evidence is weakest and the risk-benefit ratio is most unfavorable compared to alternatives.
Do not use it indefinitely without reassessment: After 4–8 weeks of use, step back and assess whether the underlying sleep issue has changed. If you cannot sleep without it, that is a signal to address the root cause rather than continuing supplementation indefinitely.
Consult your physician if you are taking any of the medications listed above, are pregnant, or are considering giving melatonin to a child.

Frequently Asked Questions

Is it safe to take melatonin every night long-term?

The long-term nightly use of melatonin remains an area of genuine scientific uncertainty. Short-term use (under 13 weeks) is supported by substantial evidence and is considered safe for most healthy adults at appropriate doses. Long-term daily use raises several theoretical concerns: the possibility of reducing the body's own melatonin production through negative feedback on the pineal gland, disruption of the natural amplitude of the circadian melatonin signal, and unknown effects on hormonal systems that melatonin regulates. No large, long-term randomized controlled trial has definitively established that nightly melatonin supplementation is either safe or harmful over years of use. Most sleep medicine specialists recommend using melatonin for specific purposes rather than as a nightly sleep-onset aid indefinitely.

Does melatonin cause dependence or withdrawal?

Melatonin is not considered chemically addictive or dependence-forming in the way that benzodiazepines or Z-drugs are. It does not produce tolerance requiring dose escalation in the classical pharmacological sense, and discontinuation does not produce the physiological withdrawal syndrome associated with sedative-hypnotics. However, a significant proportion of long-term melatonin users do experience a period of rebound insomnia when they stop — finding it harder to fall asleep without the supplement for days to weeks. This psychological and possibly mild physiological dependence is different from drug addiction but is real and underappreciated. This rebound effect is often what convinces people they 'need' melatonin, when in fact they have developed a reliance on an external zeitgeber that their brain has partially stopped producing autonomously.

What is the right dose of melatonin for sleep?

Most consumers take dramatically more melatonin than the research supports. The pharmacologically effective dose for circadian phase adjustment is 0.3 to 0.5 mg — roughly one-tenth to one-twentieth of the 5–10 mg doses commonly sold. Studies by Josephine Arendt at the University of Surrey showed that 0.5 mg produces physiological blood levels comparable to the body's natural peak, while 5 mg produces supraphysiological levels that do not proportionally improve sleep onset and may cause next-morning grogginess. The American Academy of Sleep Medicine recommends the lowest effective dose, typically 0.5–1 mg, taken 30–60 minutes before the desired sleep time for circadian phase adjustment or jet lag.

Can melatonin affect REM sleep or dreaming?

Melatonin's effects on sleep architecture — including REM sleep — are complex and dose-dependent. At physiological doses (0.3–0.5 mg), melatonin primarily acts as a circadian phase-shifting agent and does not substantially alter REM sleep architecture. At the supraphysiological doses (5–10 mg) commonly sold over-the-counter, melatonin may suppress REM sleep in the early part of the night by deepening NREM sleep, followed by potential REM rebound in the second half of the night — which many users interpret as unusually vivid dreams. If you are taking high-dose melatonin and noticing unusually intense or frequent dreams, the dose is likely pharmacologically active in ways beyond simple sleep timing. For more on the biology of vivid dreaming, see our article on why REM sleep matters.

What are the most common side effects of melatonin?

The most commonly reported short-term side effects of melatonin supplementation include next-morning grogginess or 'sleep inertia' (particularly with higher doses or poor timing), headache, dizziness, and nausea. These are generally mild and dose-dependent, occurring most frequently with doses above 1 mg. Less commonly reported effects include vivid or disturbing dreams (especially with high doses), mild depression in susceptible individuals, and irritability. In children and adolescents, experts caution about potential effects on reproductive hormone development. People taking blood thinners, immunosuppressants, diabetes medications, or CNS depressants should consult their physician before using melatonin due to potential drug interactions.